This week in IP: litigation backlog demands rethink, Amazon wins TM ruling, Continental... Managing IP rounds up the latest trademark, copyright and patent news, including some stories you might have missed By Charlotte Kilpatrick & Max Walters & Rani Mehta January 29 2021
This week in IP: WSOU most litigious NPE, UK appoints new IP judge, Trump appointees re... Managing IP rounds up the latest trademark, copyright and patent news, including some stories you might have missed By Patrick Wingrove January 22 2021
Anti-anti-suit injunctions create ‘risky’ FRAND playing fields Industry sources say the friction in Ericsson v Samsung illustrates a rising trend of unhealthy FRAND negotiation tactics By Charlotte Kilpatrick January 21 2021
Monoclonal antibody biosimilars pose unique IP challenges In-house sources from the biosimilar industry explain why ‘low inventive step’ and process patents keep new monoclonal antibodies off the market By Charlotte Kilpatrick January 21 2021
Podcast: BMS and Bird & Bird on doing major deals in a pandemic Max Walters joins Sally Shorthose and James Baillieu of Bird & Bird and Henry Hadad of Bristol Myers Squibb to discuss how COVID-19 has shaped transactional work By Max Walters January 14 2021
Opinion: What open-source software can teach big pharma A new focus on early-stage collaborative medicine could revolutionise drug research By Charlotte Kilpatrick January 14 2021
The MIP Awards and IP STARS rankings 2021 Managing IP has released the timeline for publishing the results of the 2021 MIP Awards and IP STARS research By Kingsley Egbuonu January 14 2021
This week in IP: EU watch list raises eyebrows, UK clones all EU marks, US slams COVID ... Managing IP rounds up the latest trademark, copyright and patent news, including some stories you might have missed By Patrick Wingrove January 08 2021
